Search

Robert F Kennedy Jr’s recent speech suggests that investigations into childhood vaccines and over-medication could be on the cards.

Not all patients are able to reap the benefits of groundbreaking new therapeutics. The industry must do more.

Oral solid dosage, HPAPIs, OSD development, OSD formulations, poorly soluble drugs, fixed-dose combinations, controlled release

From gene therapy to novel excipients to trends in leadership and more. Check out some of our most popular videos.

Early work from Scripps researchers uses a virtual library to synthesize plant-based metabolites: picrotoxanes.

Within two years, pharma companies may be able to rely on technology to automatically create and cross-check entire regulatory submissions.

General Manager for the Irish commercial affiliate, Karen Costello, returns to her native country to help get medicines to Irish patients faster.

Experts look at trends in antibody drug development, including the growing popularity of new modalities.

Scientists develop treatment that leads to complete regression of breast tumors in mice.

Stakeholders explain why the NIH’s move to cap indirect costs associated with research grants could damage medical innovation.